Quebec’s IVF restrictions: Economics or ethics?
By MARINA ADSHADE,
The Globe and Mail
| 12. 12. 2014
Last week, Quebec Health Minister Gaétan Barrette tabled a bill
that, if passed, will prohibit women over the age of 42 from having
access to in vitro fertilization (IVF). While the purpose of the bill,
on the surface at least, is to lessen financial strain on the health
care system, this particular section of the bill will achieve a
different outcome; it will reduce the number of births to Quebec women
who rely on the use of donated eggs to conceive.
More Related to this Story
Quebec started providing medicare for
assistive reproductive technologies (ART) in 2010 in the hope of
achieving three objectives: reduce health care costs resulting from
multiple births; enable infertile couples to have children; and increase
the number of births in the province by between 1,000 and 1,500 per
year.
Despite claims that the program
has been widely abused, the number of births to Quebec woman has only
fallen since...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...